We are live on ! Find out more
VIA

Vident Investment Advisory Portfolio holdings

AUM $2.9B
1-Year Est. Return 24.67%
This Fund
S&P 500
This Quarter Est. Return
-14.68%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
AUM
$3.34B
AUM Growth
-$500M
Cap. Flow
+$164M
Cap. Flow %
4.9%
Top 10 Hldgs %
9.82%
Holding
1,404
New
145
Increased
727
Reduced
365
Closed
141

Top Sells

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$14M
2
PG icon
Procter & Gamble
PG
+$11.3M
3
KR icon
Kroger
KR
+$10.6M
4
NOC icon
Northrop Grumman
NOC
+$8.11M
5
BIIB icon
Biogen
BIIB
+$8.03M

Sector Composition

Rank Sector Weight
1 Technology 23.57%
2 Energy 13.98%
3 Healthcare 13.42%
4 Industrials 10.8%
5 Consumer Discretionary 8.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLF icon
901
Sun Life Financial
SLF
$45.8B
$435K 0.01%
9,487
-2,207
-19% -$110K
VGIT icon
902
Vanguard Intermediate-Term Treasury ETF
VGIT
$42.3B
$435K 0.01%
+7,120
New +$436K
CTRE icon
903
CareTrust REIT
CTRE
$9.55B
$434K 0.01%
23,570
-258
-1% -$4.58K
PARA
904
DELISTED
Paramount Global Class B
PARA
$434K 0.01%
17,859
-45,456
-72% -$1.39M
SCI icon
905
Service Corp International
SCI
$11.4B
$434K 0.01%
6,261
+3,052
+95% +$209K
ED icon
906
Consolidated Edison
ED
$39.3B
$431K 0.01%
4,558
-22,348
-83% -$2.13M
NHC icon
907
National Healthcare
NHC
$3.46B
$431K 0.01%
6,165
-75
-1% -$5.25K
EEFT icon
908
Euronet Worldwide
EEFT
$2.65B
$428K 0.01%
4,264
-564
-12% -$66.8K
OPK icon
909
Opko Health
OPK
$1.04B
$426K 0.01%
168,562
+7,525
+5% +$21.9K
BSX icon
910
Boston Scientific
BSX
$73.1B
$425K 0.01%
11,443
-6,640
-37% -$270K
ERIC icon
911
Ericsson
ERIC
$32.7B
$424K 0.01%
56,683
+13,931
+33% +$114K
LFLY
912
DELISTED
Leafly Holdings, Inc. Common Stock
LFLY
$423K 0.01%
+4,700
New +$811K
LFUS icon
913
Littelfuse
LFUS
$11.6B
$411K 0.01%
1,619
+50
+3% +$12.5K
LQD icon
914
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.6B
$410K 0.01%
3,730
+1,054
+39% +$119K
FSLY icon
915
Fastly Inc
FSLY
$4.42B
$409K 0.01%
35,306
+13,893
+65% +$196K
MPT
916
Medical Properties Trust
MPT
$2.48B
$408K 0.01%
26,617
+148
+0.6% +$2.66K
DVA icon
917
DaVita
DVA
$11.7B
$407K 0.01%
5,106
+1,287
+34% +$130K
CLS icon
918
Celestica
CLS
$39.7B
$406K 0.01%
42,139
+6,800
+19% +$72.9K
SNPS icon
919
Synopsys
SNPS
$78.8B
$405K 0.01%
1,320
+473
+56% +$143K
CAN
920
Canaan Creative
CAN
$149M
$402K 0.01%
125,349
-21,562
-15% -$81.4K
ABMD
921
DELISTED
Abiomed Inc
ABMD
$402K 0.01%
1,652
-526
-24% -$142K
KEP icon
922
Korea Electric Power
KEP
$15.7B
$399K 0.01%
+45,493
New +$403K
BBWI icon
923
Bath & Body Works
BBWI
$3.89B
$398K 0.01%
14,992
-3,653
-20% -$159K
INSG icon
924
Inseego
INSG
$87.7M
$398K 0.01%
21,036
+14,666
+230% +$374K
EVGO icon
925
EVgo
EVGO
$500M
$396K 0.01%
65,954
+37,829
+135% +$360K

Similar funds

Vident Investment Advisory's Q2 2022 Portfolio in Review

As of Q2 2022, Vident Investment Advisory held 1,404 positions worth $3.34B, down 13% from $3.84B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Vident Investment Advisory deployed $164M of net new capital in Q2 2022, opening 145 new positions and adding to 727 existing holdings. Its largest new stake was Samsara: 1,361,007 shares worth $15.2M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Energy and Healthcare.

On the sell side, the largest reduction was Walmart Inc, an estimated $14M trimmed.

  • Vident Investment Advisory's largest Q2 2022 buy was Samsara: 1,361,007 shares worth $15.2M.
  • Vident Investment Advisory added most to Meta Platforms (Facebook) in Q2 2022, an estimated $13.4M increase.
  • Vident Investment Advisory's biggest Q2 2022 reduction was Walmart Inc, cutting an estimated $14M.
  • Vident Investment Advisory fully exited Cerner Corp in Q2 2022, selling an estimated $7.01M.
  • Vident Investment Advisory's ten largest holdings make up 9.8% of its $3.34B portfolio in Q2 2022.
  • Vident Investment Advisory opened 145 new positions and closed 141 in Q2 2022.
  • Vident Investment Advisory's portfolio value fell 13% quarter-over-quarter to $3.34B.

Based on Vident Investment Advisory's 13F filing for Q2 2022, filed 15 Aug 2022.